New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin

• Váldodahkkit: Juul JJ (Dahkki), Mullins CF (Dahkki), Peppard WJ (Dahkki), Huang AM (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Dove Medical Press, 2016-02-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Janelle J Juul, Caitlin F Mullins, William J Peppard, Angela M Huang Department of Pharmacy, Froedtert & the Medical College of Wisconsin, Milwaukee, WI, USA Abstract: Dalbavancin, an intravenous glycopeptide, was approved by the US Food and Drug Administration in May 2014 for use in adult patie...